NYVEPRIA is a prescription medicine used to help reduce the chance of infection due to a low white blood cell count in people with certain types of cancer (non-myeloid) who receive anti …

Jan 3, 2025 · What is Nyvepria? Nyvepria is used to prevent neutropenia (a lack of certain white blood cells) that is caused by receiving chemotherapy. Nyvepria is a form of a protein that …

NYVEPRIA™ (pegfilgrastim-apgf) This product information is intended only for residents of the United States. for Consumers: NYVEPRIATM U.S. Patient Product Information; NYVEPRIATM …

NYVEPRIA (pegfilgrastim-apgf) injection is a clear, colorless solution supplied in a prefilled single-dose syringe for manual use containing 6 mg pegfilgrastim-apgf, supplied with a 27-gauge 1/2 …

NYVEPRIA is a prescription medicine that boosts white blood cells and can help reduce the risk of infection during chemotherapy. Your doctor may recommend it for your first cycle through your …

NYVEPRIA is a man-made form of granulocyte colony-stimulating factor (G-CSF). G-CSF is a substance produced by the body. It stimulates the growth of neutrophils, a type of white blood …

Jun 11, 2020 · NYVEPRIA, a biosimilar to Neulasta, is approved by the FDA to help reduce the chance of infection due to a low white blood cell count in people with non-myeloid cancer who …

NYVEPRIA is a leukocyte growth factor indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving …

Sep 18, 2020 · Nyvepria is a medicine used in cancer patients to help with neutropenia (low levels of neutrophils, a type of white blood cell), which is a common side effect of cancer …

Sep 13, 2023 · Nyvepria (pegfilgrastim-apgf) is a leukocyte growth factor indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid …